Therapeutic Plasma Exchange in Pediatric Patients With Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease After Hematopoietic Stem Cell Transplantation: A Single-Center Experience-Reference-Cited by-同舟云学术

Therapeutic Plasma Exchange in Pediatric Patients With Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease After Hematopoietic Stem Cell Transplantation: A Single-Center Experience

Published:2022-07 Issue:7 Volume:20 Page:680-686
ISSN:1304-0855
Container-title:Experimental and Clinical Transplantation
language:
Short-container-title:Exp Clin Transplant

Author:

Akıncı Burcu,Atay Didem,Demir Yenigürbüz Fatma,Akçay Arzu,Öztürk Gülyüz

Publisher

Baskent University

Subject

Transplantation

Reference27 articles.

1. References

2. 1. Corbacioglu S, Carreras E, Ansari M, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018;53(2):138-145. doi:10.1038/bmt.2017.161

3. 2. Al Jefri AH, Abujazar H, Al-Ahmari A, et al. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management. Bone Marrow Transplant. 2017;52(4):588-591. doi:10.1038/bmt.2016.300

4. 3. Dalle JH, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2016;22(3):400-409. doi:10.1016/j.bbmt.2015.09.024

5. 4. Mahadeo KM, Bajwa R, Abdel-Azim H, et al. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol. 2020;7(1):e61-e72. doi:10.1016/S2352-3026(19)30201-7

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Veno-Occlusive Disease: A Life-Saving Novel Approach With Plasma Exchange, IVIG, and Steroid, Without Defibrotide;Journal of Pediatric Hematology/Oncology;2024-05-30